An uplifted destiny for mucopolysaccharidosis type I with heart valve involvement

被引：0
|
作者：
Raffaele Manna
Francesca Graziani
Rosa Lillo
Elena Verrecchia
Luca Ludovico Sicignano
Donato Rigante
机构：
[1] Fondazione Policlinico A. Gemelli IRCCS,Department of Internal Medicine
[2] Università Cattolica del Sacro Cuore,Department of Cardiovascular and Thoracic Sciences
[3] Fondazione Policlinico Universitario A. Gemelli IRCCS,Department of Life Sciences and Public Health
[4] Fondazione Policlinico Universitario A. Gemelli IRCCS,undefined
[5] Università Cattolica Sacro Cuore,undefined
来源：
Internal and Emergency Medicine | 2021年 / 16卷
关键词：
Mucopolysaccharidosis; Hurler–Scheie syndrome; Iduronidase; Heart valve replacement; Personalized medicine; Innovative biotechnologies; Lysosomal storage disorder;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2325 / 2326
页数：1
相关论文
共 50 条
  • [31] Diagnostic strategy of mucopolysaccharidosis type I in Tunisia
    Chkioua, L.
    Ferchichi, S.
    Khedhiri, S.
    Laradi, S.
    Bibi, A.
    Amira, D.
    Dandana, A.
    Ben Mansour, R.
    Ben Limam, H.
    Chaabouni, M.
    Froissart, R.
    Maire, I.
    Miled, A.
    ANNALES DE BIOLOGIE CLINIQUE, 2007, 65 (02) : 175 - 179
  • [32] HEART VALVE INVOLVEMENT IN FABRY CARDIOMYOPATHY
    Weidemann, Frank
    Strotmann, Joerg M.
    Niemann, Markus
    Herrmann, Sebastian
    Wilke, Mario
    Beer, Meinrad
    Voelker, Wolfram
    Ertl, Georg
    Emmert, Andrea
    Wanner, Christoph
    Breunig, Frank
    ULTRASOUND IN MEDICINE AND BIOLOGY, 2009, 35 (05): : 730 - 735
  • [33] HEART VALVE INVOLVEMENT IN ENDOMYOCARDIAL FIBROSIS
    FARRERBROWN, G
    TARBIT, MH
    BRITISH HEART JOURNAL, 1972, 34 (10): : 1062 - +
  • [34] The potential of gene therapy for mucopolysaccharidosis type I
    Pimentel Vera, Luisa Natalia
    Baldo, Guilherme
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (01): : 33 - 41
  • [35] Management of aortic stenosis in mucopolysaccharidosis type I
    Felice, Tiziana
    Murphy, Elaine
    Mullen, Michael J.
    Elliott, Perry M.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 172 (03) : E430 - E431
  • [36] Diagnosis, classification and treatment of mucopolysaccharidosis type I
    Langereis, Eveline J.
    van Vlies, Naomi
    Wijburg, Frits A.
    EXPERT OPINION ON ORPHAN DRUGS, 2015, 3 (03): : 307 - 320
  • [37] Consensus on Mucopolysaccharidosis Type I diagnosis and treatment
    Bay, Luisa
    ARCHIVOS ARGENTINOS DE PEDIATRIA, 2008, 106 (04): : 361 - 368
  • [38] Enzyme replacement therapy in mucopolysaccharidosis type I
    Miebach, E
    ACTA PAEDIATRICA, 2005, 94 : 58 - 60
  • [39] Mild forms of mucopolysaccharidosis type I (MPSI)
    Vashakmadze, Nato
    Zhurkova, Natalya
    Zakharova, Ekaterina
    Babaikina, Marina
    Rykunova, Anastasia
    Namazova-Baranova, Leyla
    MOLECULAR GENETICS AND METABOLISM, 2021, 132 (02) : S108 - S108
  • [40] Neurodevelopmental outcomes in patients with mucopolysaccharidosis type I (MPS I)
    Jeyakumar, Yaanu
    Piercy, Jamie
    Manak, Eva
    Inbar-Feigenberg, Michal
    MOLECULAR GENETICS AND METABOLISM, 2020, 129 (02) : S80 - S81
12345